The AK423 antibody recognizes human actin by western blot
DOI:
https://doi.org/10.24450/journals/abrep.2022.e761Abstract
The AK423 antibody, raised against Dictyostelium actin, recognizes human actin by western blot; AE765, AK692, AO233 and AO234 do not.
Introduction
Actin is one of the most abundant proteins in eukaryotic cells, and a major structural component of the cytoskeleton, forming networks of microfilaments in the cytoplasm of cells. The human genome contains six genes for actin (three for α-actin, one for β-actin, and two for γ-actin) (Pollard, 2016). Five recombinant antibodies (AE765, AK423, AK692, AO233 and AO234) were tested for their ability to label actin by immunofluorescence.
Materials & Methods
Antibodies: ABCD_AE765, ABCD_AK423, ABCD_AK692, ABCD_AO233 and ABCD_AO234 antibodies (http://web.expasy.org/abcd/, ABCD nomenclature) were produced by the Geneva Antibody Facility (http://unige.ch/medecine/antibodies/) as mini-antibodies with the antigen-binding scFv fused to a rabbit IgG Fc. The synthesized scFv or VHH sequences (GeneArt, Invitrogen) correspond to the sequences of the variable regions joined by a peptide linker (GGGGS)3 (see Table 1 for clone names and references). HEK293 suspension cells (growing in HEK TF medium, Xell 861-0001, supplemented with 0.1% Pluronic F68, Sigma P1300) were transiently transfected with the vector coding for the scFv-Fc or VHH-Fc. Supernatants (see Table 1 for individual yields) were collected after 4 days. As positive control, a commercial anti-beta actin antibody (clone 2D4H5, Proteintech 66009-1-Ig), raised against human ACTB (Uniprot P60709), was used.
ABCD | Clone | Epitope | Reference | Yield ( mg /L) |
AE765 | SA1A | Human actin and alpha-actinin | Victor et al., 1992 | 70 |
AK423 | mAb 236 | Dictyostelium actin (Uniprot P07830) | Lima, 2019 | 10 |
AK692 | Nb141 | Human ACTB, (Uniprot P60709) | Jovčevska et al., 2014 | <5 |
AO233 | 3-1 | Human ACTB, (Uniprot P60709) | Persson et al., 2013 | 90 |
AO234 | 3-2 | Human ACTB, (Uniprot P60709) | Persson et al., 2013 | 30 |
Antigen: HEK cells grown in DMEM GlutaMAXTM (Gibco 31966) supplemented with 8% Fetal Bovine Serum (Gibco 10270) were used.
Protocol: 5x106 cells were pelleted and lysed for 15 min in 100 L of ice-cold lysis buffer (25 mM Tris-HCl pH 7.4 + 0.5 % Triton X-100 + 120 mM NaCl) containing protease inhibitors. Lysate was centrifuged 15 min, 10’000 g at 4 °C to remove nuclei. One volume of sample buffer was added to the lysate (20.6% (w/v) sucrose, 100 mM Tris pH 6.8, 10 mM EDTA, 0.1% (w/v) bromophenol blue, 4% (w/v) SDS, with or without 6% (v/v) -mercaptoethanol) and boiled for 15 min at 95 oC. Dilutions of each sample (500’000, 100’000, 20’000 and 4’000 cells) were migrated (150 V, 45 min) in a 4-20% acrylamide gel (Genscript, SurePAGE Bis-Tris, M00655), and transferred to a nitrocellulose membrane using a dry transfer system for 7 minutes (iBlot gel transfer device, Invitrogen IB23001). The membranes were blocked during 60 min in PBS containing 0.1% (v/v) Tween20 and 7% (w/v) milk, and washed once for 15 minutes in PBS + 0.1% (v/v) Tween20 (PBS-Tween). The membranes were then incubated overnight at RT with the anti-actin antibodies (for the ABCD antibodies, final concentration 5 mg/L in PBS-Tween; for the Proteintech antibody, 0.05 mg/L). The membranes were then washed three times (15+15+10 min) in PBS-Tween, incubated for 1 hour with the horseradish peroxidase-coupled goat anti-rabbit IgG (Sigma-Aldrich A8275, dilution 1:3000, for the ABCD antibodies) or anti-mouse IgG (Biorad 170-6516, dilution 1:3000, for the Proteintech antibody) and washed three times (15 min) in PBS-Tween. The signal was revealed by enhanced chemiluminescence (ECL) (Amersham Biosciences) using a PXi-4 gel imaging systems (Syngene).
Results
Of the five anti-actin antibodies tested, only AK423 specifically recognized actin from HEK cells, detecting a band around 45-50 kDa, similar to the positive control (Fig. 1). AK423 also cross-reacted with a band of higher molecular weight (~130-170 kDa). The other four antibodies (AE765, AK692, AO233 and AO234) did not detect any specific bands (Fig. 1). Fig. 1 shows results for reduced samples; non-reduced samples show exactly the same migration and detection pattern (data not shown).
Conflict of interest
The authors declare no conflict of interest.
References
Arsimoles D, D’Esposito AG, Gaspoz V, et al. The AJ519 antibody labels the human TAC/IL2RA protein by immunofluorescence. Antibody Reports, 2020, 3:e118. doi:10.22450/journals/abrep.2020.e118
Jovčevska I, Zupanec N, Kočevar N, et al. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers. PLoS One. 2014; 9(11):e113688. PMID: 25419715
Lima WC. The AK423 antibody recognizes Dictyostelium actin network by immunofluorescence. Antibody Reports, 2019, 2:e54. doi:10.22450/ journals/abrep.2019.e54
Persson H, Ye W, Wernimont A, et al. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies. J Mol Biol. 2013; 425(4):803-11. PMID: 23219464
Pollard TD. Actin and actin-binding proteins. Cold Spring Harb Perspect Biol. 2016; 8(8):a018226. PMID: 26988969
Victor KD, Pascual V, Williams CL, Lennon VA, Capra JD. Human monoclonal striational autoantibodies isolated from thymic B lymphocytes of patients with myasthenia gravis use VH and VL gene segments associated with the autoimmune repertoire. Eur J Immunol. 1992; 22(9):2231-6. PMID: 1516616
Downloads
Published
Section
How to Cite
License
Some rights reserved 2022 Anna Marchetti
This work is licensed under a Creative Commons Attribution 4.0 International License.